Check the Batch
Class IITerminated in FDA datasetRecall initiated Jul 8, 2014

Lindberg B-Complex, 50mg, 60 capsules (

Recalling firm: Nutrition Express Corporation

Why it was recalled

Nutrition Express is recalling Lindberg B-Complex and Fitness Multi 1 vitamins because the amount of folic acid in the products was found to be higher than the label claim.

Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Dec 18, 2014.

Check your package

Compare the exact product and package details with the label you have.

ProductLindberg B-Complex, 50mg, 60 capsules (UPC 092865236601), 120 capsules (UPC 092865236120), 240 capsules (UPC 092865236243).
UPC092865236120, 092865236243, 092865236601

FDA code information

Lot no. 3092328, 4032606.

Match the product, package size, and code together. A missing match does not guarantee safety.

Full FDA record and distribution details

Original product description

Lindberg B-Complex, 50mg, 60 capsules (UPC 092865236601), 120 capsules (UPC 092865236120), 240 capsules (UPC 092865236243).

Extracted codes and context

TypeCode / valueContext
UPC092865236120Lindberg B-Complex, 50mg, 60 capsules (UPC 092865236601), 120 capsules (UPC 092865236120), 240 capsules (UPC 092865236243).
UPC092865236243psules (UPC 092865236601), 120 capsules (UPC 092865236120), 240 capsules (UPC 092865236243).
UPC092865236601Lindberg B-Complex, 50mg, 60 capsules (UPC 092865236601), 120 capsules (UPC 092865236120), 240 capsules (UPC 092865236243).

Original FDA recall reason

Nutrition Express is recalling Lindberg B-Complex and Fitness Multi 1 vitamins because the amount of folic acid in the products was found to be higher than the label claim.

Recall details

Recall number
F-2315-2014
Event ID
68808
FDA status
Terminated
Initiated
Jul 8, 2014
Reported
Aug 20, 2014
Classified
Aug 13, 2014
Terminated
Dec 18, 2014
Quantity
667 units
Location
Torrance, CA, United States
Initiation type
Voluntary: Firm initiated
Notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Where it was distributed

CA

FDA source record · F-2315-2014

Data updated September 16, 2026. View official FDA data ↗

Follow official FDA and manufacturer guidance.